Pfizer reported that Lyrica didn't satisfy the top effectiveness goal of a Phase III trial for treating patients with diabetic peripheral neuropathy.
Lyrica not effective for diabetic neuropathy pain
SmartBrief Job Listings for Health Care
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore